Roche Holding AG | Key People and Executives
Severin Schwan
Chief Executive Officer & Executive Director
Claudia Süssmuth Dyckerhoff
Director
Richard P. Lifton
Non-Executive Director
Bernard J. Poussot
Non-Executive Director
Peter R. Voser
Non-Executive Director
Paul Bulcke
Non-Executive Director
John Irving Bell
Non-Executive Director
André S. Hoffmann
Vice Chairman
Andreas Oeri
Independent Non-Executive Director
Severin Schwan
Chief Executive Officer & Executive Director
Alan Hippe
Chief Financial & Information Technology Officer
Stefan Frings
Head-Medical Affairs for Oncology
William Pao
Head-Pharma Research & Early Development
Roland Diggelmann
CEO-Roche Diagnostics
Daniel O'Day
CEO-Roche Pharmaceuticals
Per-Olof Attinger
Secretary-Executive Committee & Head-CEO Office
Michael D. Varney
Head-Genentech Research & Early Development
Urs Jaisli
Chief Compliance Officer
Claudia Süssmuth Dyckerhoff
Director
Richard P. Lifton
Non-Executive Director
Bernard J. Poussot
Non-Executive Director
Peter R. Voser
Non-Executive Director
Paul Bulcke
Non-Executive Director
John Irving Bell
Non-Executive Director
Elhan Webb
Investor Relations Officer
Melanie Wolf
Investor Relations Coordinator
Sabine Borngräber
Investor Relations Officer
Eva Losert
Investor Relations Coordinator
Beatrice Hau
Investor Relations Coordinator
Bruno Eschli
Investor Relations Officer
Birgit Masjost
Investor Relations Officer
Nicolas Dunant
Head-Media Relations
Stephan Feldhaus
Head-Group Communications
Karl Mahler
Head-Investor Relations
Cristina A. Wilbur
Head-Group Human Resources
Gottlieb A. Keller
Secretary & General Counsel
André S. Hoffmann
Vice Chairman
Andreas Oeri
Independent Non-Executive Director
| Address |
Grenzacherstrasse 124
Basel Basel-Stadt (Basle Town) 4070
Switzerland
|
|
Employees
|
- |
| Website |
http://www.roche.com |
| Updated |
09/14/2018 |
| Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. |
